| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Nishan Garabedian Christopher last filed a Form 4 in February 2015, as President and CEO at SRPT. Nishan Garabedian Christopher's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 29,552 shares of SRPT. Net of sales, the SRPT filings show accumulation of 800 shares.
Nishan Garabedian Christopher has 1 Form 4 filing on record in February 2015, as President and CEO at Sarepta Therapeutics (SRPT), 2015.
The 3 reported transactions were 2 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $9K and no sales.
The only open-market purchase was 800 shares of SRPT at an average $11.81 on February 27, 2015, about $9K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2015 | SRPT Sarepta Therapeutics, Inc. | President and CEO | Buy | 800 | $11.82 | $9,452.00 | +2.8% |